Orion Biotechnology Canada Ltd. — Form D/A

Orion Biotechnology Canada Ltd. of OTTAWA, ONTARIO, Z4, a company, filed a Form D amendment with the SEC on 2025-08-26. The offering totals $15.0M, of which $6.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Lonnel CoatsDirectorOttawa, A6
Jean ForcioneDirectorOttawa, Ontario, Z4
Mark GroperDirectorOttawa, Ontario, Z4
Katie HewittDirectorOttawa, A6
Anatolii KlepatskyDirectorOttawa, Ontario, Z4
Bradford SmithDirectorOttawa, Ontario, Z4
Praveen TyleDirectorEncinitas, CA
John JussupExecutive OfficerOttawa, Ontario, Z4
Anatolii KlepatskyExecutive OfficerOttawa, Ontario, Z4
Praveen TyleExecutive OfficerEncinitas, CA
Theresa FirestoneDirectorToronto, A6
Theresa FirestoneExecutive OfficerToronto, A6
Mark GroperExecutive OfficerOttawa, Ontario, Z4
Jason BurkeExecutive OfficerOttawa, Ontario, Z4
Jason William BurkeExecutive OfficerOttawa, A6
Jean William ForcioneExecutive OfficerOttawa, A6
John William JussupExecutive OfficerOttawa, A6
Anatolii KlepatskyiDirectorOttawa, A6
Mark HechtDirectorOttawa, A6
Rudolf BomDirectorOttawa, A6
Rudolf BomExecutive OfficerOttawa, A6
Anatole Sheila KlepatskyDirectorOttawa, A6
Anatole Sheila KlepatskyExecutive OfficerOttawa, A6
Thomas Sheila HechtDirectorOttawa, A6
Thomas Sheila HechtExecutive OfficerOttawa, A6

Other filings by this issuer (5)

FiledFormOfferingSold
2024-07-23D$5.0M$743K
2023-03-15D/A$15.0M$9.9M
2021-06-22D/A$15.0M$5.4M
2021-06-15D$15.0M$5.4M
2020-10-09D$605K

More